) The metropolitan Detroit area is home to a population that is ethnically and culturally diverse, and the Population Studies and Prevention Program brings together faculty with a variety of scholarly interests whose research is based on this diversity. The Program is composed of two interactive groups: 1) Population Studies, with a research emphasis on population-based studies of cancer etiology; and 2) Prevention, with a research emphasis on studies designed to prevent and/or control the development of cancer within this population. Our population-based studies focus on the interface between genetic and environmental exposures and their roles in the subsequent development of cancer. Although several different cancers are under investigation, our primary interests are in the etiology of breast, prostate, and lung cancers. Our prevention studies emphasize the roles that nutrition and tobacco prevention/cessation play in the prevention of cancer. Our primary interests involve the preventive effects of soy isoflavones, lycopene, folic acid, zinc, increased fruits and vegetables, and a low fat diet in a variety of cancers. The effects of these interventions on oxidative DNA damage, lipid peroxidation, serum sex-hormone levels, tissue markers of cell growth and differentiation, signal transduction, and growth factors are currently under investigation. We have 27 primary members and 10 clinical members within the Program. Currently, 18 of these members serve as Principal Investigators on 35 peer-reviewed research projects that are supported at the national level. Although faculty within the Program collaborate with faculty from all the other programs of our CCC, we have especially strong inter-Programmatic collaborations with investigators in the Breast Cancer, Prostate Cancer, and Molecular Biology and Genetics Programs. Approximately 80% of the research within this Program is supported by the CCC Core facilities and the research efforts of Program investigators are considerably enhanced by these Core facilities.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA022453-23
Application #
6573365
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2001-12-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
23
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Wayne State University
Department
Type
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Feldmann, Daniel P; Cheng, Yilong; Kandil, Rima et al. (2018) In vitro and in vivo delivery of siRNA via VIPER polymer system to lung cells. J Control Release 276:50-58
Thakur, Manish K; Heilbrun, Lance; Dobson, Kimberlee et al. (2018) Phase I Trial of the Combination of Docetaxel, Prednisone, and Pasireotide in Metastatic Castrate-Resistant Prostate Cancer. Clin Genitourin Cancer 16:e695-e703
Wang, Zhaoxian; Sau, Samaresh; Alsaab, Hashem O et al. (2018) CD44 directed nanomicellar payload delivery platform for selective anticancer effect and tumor specific imaging of triple negative breast cancer. Nanomedicine 14:1441-1454
Vaishampayan, Ulka (2018) Advantages and Adversities of the Weighted Toxicity Score. Clin Cancer Res 24:4918-4920
Kim, Seongho; Wong, Weng Kee (2018) Extended two-stage adaptive designs with three target responses for phase II clinical trials. Stat Methods Med Res 27:3628-3642
Ravindra, Manasa; Wilson, Mike R; Tong, Nian et al. (2018) Fluorine-Substituted Pyrrolo[2,3- d]Pyrimidine Analogues with Tumor Targeting via Cellular Uptake by Folate Receptor ? and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis. J Med Chem 61:4228-4248
Beebe-Dimmer, Jennifer L; Albrecht, Terrance L; Baird, Tara E et al. (2018) The Detroit Research on Cancer Survivors (ROCS) Pilot Study: A focus on outcomes after cancer in a racially-diverse patient population. Cancer Epidemiol Biomarkers Prev :
Ahmed, Zainab Sabry Othman; Li, Xin; Li, Feng et al. (2018) Computational and biochemical studies of isothiocyanates as inhibitors of proteasomal cysteine deubiquitinases in human cancer cells. J Cell Biochem 119:9006-9016
Desai, Pinkal; Wallace, Robert; Anderson, Matthew L et al. (2018) An analysis of the effect of statins on the risk of Non-Hodgkin's Lymphoma in the Women's Health Initiative cohort. Cancer Med 7:2121-2130
White, Donna L; Hoogeveen, Ron C; Chen, Liang et al. (2018) A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women. Cancer Med 7:2180-2191

Showing the most recent 10 out of 826 publications